LAP ReS￿reh
(A company limited by guarantee)
CompaDy Registration Number 06752342
Cb*rity Number 11311523
UNAtfDITED REPORT AND FINANCIAL STATEMENrs
For the y￿r ended 30 November 2025

LAP Reqeareh
Report #nd Fin*n¢i41 Sialementj
For the )ear ended 30 November 2025
Contents
Pag¢s=
Rewrt of the Trustees
2to5
Re￿rt of the Independent Examiner
Statement of Financial Activities
Balance Sheet
Notes to the Financi81 Stsiements
9andlO

LAP Rcqellrch
Report and FinAncial Siglementj
For the ended 30 November 2025
Report ofihe Trn5ttts
The Trustees ore pleased to present their annual rem together with th¢ financial staiements of the charity for
the l'ear ended 30 November2025 iwhich are also prepared io meei the requirements for a direciors. repofl and
ccount5 for Companies A¢1 purposes.
The financial siaiements ¢(￿pIY with ihe Charities Aci 2011. the Comp8nies Act 2￿6, the Memorandum and
Articles of A$50ciation. and Accounting and Rewrting by Charities.. Sthiemerjt of Recommended Praciic¢
applicable to charities preparing their accounts in a¢cordan¢¢ with the Financial Reporting Stsndard applicable
in ihe UK and Republic of Ireland IFRS 102) (effective l January 2015).
Purpose and Aclivities
LAPResearch wa5 Set up in 2(K)7 by two surgeons who speciali5e in the area of medicine known as
Hepaiopancr¢aticobiliary medicine {HPB for short). They recogni5ed the need for a charity dedicated to
research into the wide f8J)ge of Conditions and illnesses thai affert all of these organ$, rather than focus on on¢
particular organ or disease. They fonnally incorporaied the thariry in 2008 with the vision lo find novel.
preveniativ¢ and curative treatments for liver. pancreatic and bill￿ dise&8es and the rnission to fund the highest
qualiE)' research into disease5 of the liver, pancrea5 and biltary tree whilst educa(ing healthcare professionals and
oth¢rs affecied about outcomes.
The liver. pancreas, gallbladder and biliary tree are affecied by illnesses that range from the simple and benign.
io the life changing artd fatsl. Although most people hav¢ heard of the liver in relation io new5 siories about
alcohol consurnption, f¢w¢r ￿0P[e have heard of the pancreas and its crucial rol¢ in th¢ lyxly. whilst the biliary
tree and gallbladder are complete mysteries io m051. This relatively poor awareness of these organs and the
medical speciality thai deals with them rnakes fijnding much-needed research into their Ca￿seS and trearnent
very difficuh.
The need for this fijnding 15 clear. liver cancerand pancreatic ￿l¢¢T ¢lairn thousands of liyes in the UK each
}'ear: pancreatitis is a FMJorly Underst(￿ condition affects all ag¢ groups and remaills a killer of youn¥ and
old altke- and cancers of the biliary tree have 50m¢ of the lowest survival fdies of any rype of cancer. Pancreaiie
cancer will be the fourth deadltesi fonn in Britsin by 2026 due to late diagnosis: suThival raies have not changed
m¢aningfully for 40 years due to a lack of research funding. Incidences of pancreaiiiis are increasing by nearly
30/0 per )'ear and there is no known cure. Whi15t other organs and diseases have been much higher in profil¢ over
recent decades and investment in research into these areas has produced significani advances in preventiOTt,
diagnosis and tream?ents, the liver. pancreas and biliary trtt have not been of sirnilar focus.
Fin*nei*l review
The charity is funded by donations specific fund-rdi5ing o¢tiViii¢s and SUPEX)rte¢L in the main. by volunteer5.
The Trustees consider the resulis for the yeario be satisfactory wilh a nei outgoing resources of £32,577. m3inl)'
due io orJ¢ very generous benefactor, compared to I￿1 year with a net outgoing resources of £140.995 and Can
continue lo achfreve their objectives based on their x¢ymula*d reserves position.
As of 30 November 2025, there were asseis of £315P44, which all are unrestricted ￿nds. The ¢otnpany has
a very low level of administrationaI expeu5es io m¢¢t ￿h¢r thon gwts to ￿nd new pieces of r¢￿arCh and EO
promtsie public awareness of the diseases of ihe liver, pancrrd5 and biliary iree. The charity ha5 no invesiments
or IIKed asseis. all of its nei assets are held in bank accounis.
I hr puliLy uf the charily is to build up lis reserves 10 promote individual and coniiTruing research iiork. li both
lids 41nd. In the I'uture. aims io Iiav¢ 5ufficielll r¢serve5 10 n]eei boih imniediaie short-iemi needs dnd Iiiiib-ll'iiii
LiJJnniiLni¢nis lo fuluT¢ research. I'he irustees also keep sufiicieni res¢rv¢s lo nie¢l the nexi ihr¢¢ iii()ilih￿ liiiiiliii¥

l.Al> ReicArch
Report and Fingncial Statements
For the vegr ended 30 November 2025
i)f elpenses including those expense5 inctsrred to promote generdl awareness into liver, pan¢r¢ali¢ and bile
In (he lasi fci* l'ears. the charity has invesied more activety and key achievements from the LAP Research
funding includes
l. The Clinical Research Fellow ICRF) who 15 employed within the programrne has successfully
Completed the fiN-year upgrade of his MI¥Res) programme at QMUL.
2. The CRF has a150 compleied Several local and national presentations at scientific and #¢ademic
mtttings.
TTUStee& Strnrture. Govern*nee #nd Man*gement
The company wa5 incorpornted limited by guarantee on 18 November 2(rf)8. It is governed by the arEicles and
memorandum of association. li 15 regisiered with the Chariiies Commission.
A Board of Trnstees governs the charity. The following Trnsttts who served during the year and up to the date
of sÈgning of thi5 re￿rt who were also appx)inted as Directors are:
MrG Bond-smith
Mr D Allen
Dr William Ala72wr continues lo be responsible for the academic aLttviti¢s of LAPResearch. This role involves
velling proposed project% ¢ll5ufiDg goLNJ clinical governance. awed milestones are achieved and the projects
are all complded in a timely m8nDer.
The B(Trard of Trustees is actively SUPFKJrted by a number of people who w¢ll acquainted with the Workings
and need5 of the charity.
Chxrity AdmlnbtratiOD:
New. trltsttts will be apwTrinied ￿ and when the charity needs additional m￿lee$. app)intments are made by the
Board of Trusitts. New member5 will b¢ s¢l¢aed b85ed uF¥)n their existing skills and eX￿rienCe. Appropriate
trdilling is organised for new and existing trustees &8 necessary. All n¢w members will be provided wilh a pack
thal explains their duties to ihe charity and their lawful r¢srK)n$ibilities both a5 members and as Trusiees.
Ri5k5 #nd uneert*inties
"rh¢ Trustees actively review the major risks that the Charity faces on a re8ul¥ b4Sis and ￿lIeVe thai
Ill41tntsining reserves ai current levels, Combined with an annual review of financial systerns will provide
sutTici¢nl resources in ihe eveni of adverse condition5.

l.Al• Rege4rch
Reporl Trin*D¢ig151gtement8
For ihe l'ear ended 30 N￿'ember 2025
PIBns for Period5
The Charity no￿ has h¥0 live projects..
l) The MOTION studv
This is a pilot swd!. io deierniine ihe predi¢tiie value of plasma progastrin leve15 in sifting out those patients
ho actuall) hai'e a diagnosis of cancer on the Mo ￿¢¢k woit {2WW) lower gAsirointestinal paihwa). The study
aimf lo prospeciii'¢l} ￿¢ruit a lotal of 582 No ￿eCk wait pati¢nts from a single sile {Ro}al London Hospital.
Barts Ilealth NHS T￿$1) over a ￿.0 year period or until compl¢Lion of recTUitment.
Ihe MOTION SDJd)' commenced active recrnimieni in July 2025 and have made 5ignifican( progress wilh
participani accrnal. In the one.year recnjitment peri￿J. the swdy completed more than 559/0 of lis re¢nJiimcnt
tar?ci. The S￿d). activitics have also idenlified a larger p)ol of ￿tentIal participants who are already being
screened. HO￿.eNer. ￿orkfOrCe limioiions does noi allow to recnjii ai a fast¢r pace at present.
The swdl ieam aniicipates a fiirther six io eight month5 of ￿tru1￿ment io r¢ach the iolal sjmple size. In this on
ear period. the firs(3(H)+ pl￿[na samples have also been analysed for the progasthn leve15 at the Progra5trin
Nlanufacturing Lab. France. The results are kew blinded and will ￿ revealed at the end of th¢ sludw period
befo￿ the frnal dats anal)'sis.
2) Gr#DI to HPB Roboti¢ Progr*mme *t Oxford Uniyenity H05pil&ls IYHS Foundgtiott Trust
This a single grant award of £25,W) to Supp￿ the integrdtiOD of a digithl plarfom into the HPB robotic
progT3mme. This plaifoTm helps with the r¢cordtng of miniM￿]Y tnv&sive operating io support edu¢atioft of the
ider team and development of technical skills.
Other key achievements since the )'ear end date from the LAP Research funding includes:
l. The following firsi publiotion arising frorn the IKMIY of fiwded work has been ac¢¢pted for publication b). the
5cienirfic journal. Biomarker Insights after [￿erre¥leW.
'"Unlocking Colorrftal Cancer Diagnostics with Circulating Progrdstrin IhPG80): A Scoping
Review. Authots: Butnari V. Dinkar DK, Jaya5inghe J. Patel M, Rajenthan N. Raouf S, MadapuTa
PM. Thaha MA. Date accepied for publicaiion- 22nd of July 2026.
? A Second manuscripi 15 currenily under preporniion and will be submitted to 'British Joumal of Cancer. by
No%ember ?026."Blood-based Biomarkers in Colorecthl Canter: A Review and Mets-analysis of Dia¥nosiic
Accurac%.. Clintcal Performance and Future Dire¢tions-.
Resern'es Polie).
'rh¥ fru51ees are of the opinion that the present level of res{￿[CeS iogether with the level of designated re5¢rves
15 ad¥quai¢ to supwrt the continuation of the Charities aciivities for the medium ienn.
Th¢ Charity has a stmegy ￿ raise further miM)ies w fund som¢ research Fffojects. The Charity's web pages hai'e
been Tndierially enhanced and are now up to date and much more inforn)aiive and ihe Charity 15 noiv lookinb Ivr
d Consultsni with fwidraising ski115 10 generate reserves suATKieni for ihe longer-terni proj¢¢is.
Reference snd admiDffistrntive iDformatio
L vmpanj number
06752342
C'lidTiI J numb¢r
1130523
J<rbllStvr¢d olltce
26 Stone M¢&dow5, Sione Meadows. Oxford. OX? 6TQ
ALLuuni4tnis
Brendan P Ilyrn¢ & Co Lid- BPD Accoiinianis
14dnker5
IIS14C

LAP Rc%farch
Report and FinaneiAI StAtemenls
For the vear ended 30 No)ember 2025
Trusttts Respothsibilities
The TTUSttts. ls dirtaots, are re4MJnsible for preparing an Annual report and financial statements in accordan¢e with
applicable law and United Kingdom Accounlin8 Stsnd8rd5 Iunited Kingdom Generally Accepted Accounting Praciicf l.
Compans. law require5 the directors io prepare financial sthtements for each year which give a true and fair view of the
state of affairs of the charitable company and of the incoming rtsources and Èpplication of rewurces. including the ipcome
and expenditure for that peri￿. In preparing the fLnancial stsiements, the directors are required to".
select suitsble accounting ￿lliCI¢S and then wly them consisienity:
obseNe the methixls and principles in the Charities SORP.
make judgements and estimates th* are reasonable and wwlenL
stste whether applicable UK xcouniing standards hav¢ been followrt 5ubjeci to any material departUTe5
disclosed and explained in the f￿anCial swem¢nts;
prepare the F￿an(la] statements on the going con¢wn basis unless it is inappropriate to presume that the chari
will conttnue in I￿lneSs.
The Trulltts. &s directors wt resrx)n$ibl¢ for keeping proper xcounling records that disclose with reasonable accuracj ar
any time the financial Nysition of the charity 8Dd to enabk tbem io ¢nsur¢ that the r]natt¢iJl stst¢rnents comply with ¢he
Companie5 Act 2￿6. They are a150 reSFrfM￿ib]e forsafeguwding the assets of the tharity and the group and hence iaking
reasotthle ￿ep5 for the prevention and detertion of fraud and other irregularitics. The Trus¢e¢4 ￿ diredors are
res￿nsIble for the maintenallce and inlegrity of the ciryrnte and f￿ancial infortnation includ¢d on th¢ charitable
ornpany's websttr.
St•t¢JD¢nt *s to diKIos¥r¢ to 0￿r AttoMnl*Dts
tn so far as the Tntsw. as directors aff aware * the time of approving our annu41 repxt:
th¢re is DO relevant infonnatiiMI. b¢itig infcqmation need￿ by th¢ 4¢¢(xthtsnt in connection with preparing their
reporL of which the a¢countant is unaware, and
having made ¢nquiries of fellow Trusltts and the that they ougbt io have individually tsken. have
each taken aEI sws that hejshe is obliged th tske as an 4ryK)intrd dir￿￿r in order to make themselves aware of
any ttlevant audit infonnati(m and to esthblish th)t the accounlant is awart of that inforn)ation.
Thi5 reFth was approv￿ by the 28A)9r2026 and signed their behalf
Mr G ljund-smith

LAP Rcscarch
Roporl And Fin#neiAI Stalementy
For the i'eAr ended 30 i%oiember 2025
Indcptndtnt ex*min¢r's report to the Trnstees of"LAP ReS￿rth,
In accordance wilh the engag¢m¢nt letter daied 23 Jyty 2013, and in order to assisi YOU to fulfil your duiie5 under Ihe
Companies Ad 2￿6. we have compiled the financial 5talements of the company which comprise the Siatemeni of
Financia5 Aaiviiies. Balance sh￿ and the related notes fmm the accounting r¢¢ord8 and inforn)aiion
explanations you have given io us.
This ye￿rt is made io the Company's Board of Tn￿l￿s. as Direciors. as a i￿. in accordance with the temis ofour
en¢a£ement. Our work h&$ been undertaken so that we might compile the financial sthiemenls that we have been
engaged io compile. ryrt io the Company's Board of Trusiees. as DirectOT5 that we have done 50. and state those
rnallers thai we have agreed io stsie to them in this reEKrt and for no other puryx)se. To the fijllest exient permitted by
la￿.. M'e do not a¢cept or Lssume responsibility to anyone other than the Company and the Company's Board of
Trnstees. &s Director¥ as a body. for our work or for this reprL
You have acknowledged on the Balance Shttt for the year ended 30 November 2025 your duty to ensure that the
company ha5 kept prop¢r ¥eountsng Tecor&8 and to prepare financial ststements that give a true and fair view under
the Companies Act 2￿. You consider the company is exempt from the 5tsty10ry requirement for audit for the
We have been in5trud¢d to cany aD audit of the financial ststernent& Forthis reason. we have noi verified the
accuracy or completeness of the ¥countiti8 record8 or inforn)ation and explanations you have given to us and we do
no( therefore. express any (yinion on the fxt)ancial sthtements.
Brendao P Byrne & Co Accountants
28109r2026
12 Old Bexley Lane
Bexley
Kent
DA5 2BN

.Al' ReseArch
Report And Fin4n¢ig1 .Fitalemenly
For the )ear ended 30 Noi'ember 2025
Siatemtnt of Flfv*ncial A¢tlvliits iThelMdipg Income And Expendllutt A¢¢ovfvt
Totil
Total
funds
fund5
2025
2024
Not
PolD Evenl
Other
INCONIE:
Don*iions *nd kgaeies
'olun￿Tr donations
Ib
10,864
10.864
12.176
lthcome from ch*ritxble •ctlvlti¢s
Oiher income- GTants
Oiher tr*ding *rtiTrities
Fundraising events
Ib
219.545
219.545
142.4) I
Id
1.163
TOTAL IliCOME
219.545
10,864
230.409
155.970
EXPEP*DITURE:
Charithble *etivities
Resta￿h grants aw'arded
Goi'emance and support costs
Raising fuDds
Fundraising
133290
32.903
133290
32,903
?5.981
96.793
96,793
53.340
TOTAL EXPENDITURE
Ic
96.793
166.193
262.986
?95.844
ET INCOMEI(EXPENDITURE)
122.752
(155,329)
(32,577)
(140.99)1
l funds brought forward
347.911
488.90)
Trdnsf¢rs bdween funds
TOT AL FLIliDS CARRIED FORWARD
i15.344
i47.911
NIJ funds are restri¢t¢d in nature.
1"11¥ sldtvmeni of fEnancial affliviiies includes all gains and10sses recognised in ihe year.
All Jncome and expendilur¢ d¢rive from continuing ￿NIonS.
I he n¢)i¢s on pages 10 and I I fom] pan of these financial siaiements.

Roport FinAnci41 SiAlemenls
For iht Trtar ended JO NoTrember 2025
B*l*ftce sh￿ Istatemenl of Assets And Llibiiiilej) as *t 30 November 2025
Notes
2025
21124
Filed assets
Current *ssets
Bank and ¢￿h ai hand
317 122
317,122
348 778
348.778
Curreni li•bilities
Creditors falling due within one year
(1.788)
(867)
Nei Cu￿ent ￿ets
315J44
347.911
Net *ssets
347.911
Gefternl fund
Unrestricted funds
le
315.344
347,911
315,344
347.911
For the year in question the company wa5 entitled io ex¢m￿lon under section 477 of the Companies Act 2006
relating io small companie5.
Directors. reS￿nSIbl111ies.
I l The member5 have noi required the company to (A)thin an audit for its accounts for the year in question in
accordance with section 476.
?) The dir¢etors acknowledge their Tesponsibilities for complying with th¢ requirements of the Aci with respect
10 accounting records and the preparaiion of accounts.
The￿ accounts have been pr¢pared in Jccordance with the provi5ion$ applicable to companies subjeci to the
small Gompanies, regime and the Charities Aci 2011.
The accounts were approved by the Board of TnJste¢s on 28109Q020
Mr G 13ond-Smith
'I'he nutes (MJ pages 9 and 10 forn] part of these fmancial 5ta¢¢ments.

LAP Rc4c#r¢h
Report Financial Statcmenls
For the iegr ended 30 November 2025
ote5 lo the Atcounts
Accounting policies
Basis of preparntion
The financial ststements have been prepared in accordance with Accounting and Reporting by Chariiies.. Statcmeni
of Recornmended Practice applicable to charities prep3ring their accounts in accordance wilh the Financial Reporting
S(andard applicable in the UK and Republic of Ireland (FRS 102) (etTeciive l January 2015)- (Charities SORP IfRS
10))). the Financial Reponing Standard applicable in the UK and Republic of Ireland (FRS 102) and the Compani¢s
Aci *006. LAP Research meets the definition of a public benefit ¢ntity under FRS 102. Assets and liabilities are
initiall). reco£nised ai himorital cost or transaction value unl¢ss oth¢rwi5¢ Stated in the ￿ levant accounling policy
noie(sl.
b. Income
Fundraising income is recognised when there is 4 reasonable assurance of receipt. volwitrry donations are
reco_onised M,hen received. The Charity 15 not required to be registered for VAT. All monies received were
unrestricted in nature.
Expendiiure
Resources expended are recwised in the wiod in which they are incurt they include VAT which cannot be
r¢¢oVer￿1 but do not include the value of services provided by volunteers.
Iniere
Ini¢r¢5t on funds held on de￿￿1t is included when Yeceivable and the arnount can be rneasured reliably by the chariry:
this is noTmally up)n noiification of the interest paid or payable by the Bank
Funds
Unrestri¢ted funds are available to S￿nd on activities that further any of the purposes of charity
f. Other
The Chariry has no ftxed asse￿ no oper*ing leLse& no staff nor pensiort oblig1tio￿.
Iwl St*t115
The charity is inc0rFK￿￿ed as a company limited by guardn*e having no share capital and in accordance with
the memorandum of &swi*ion, every mernber is liable io ¢ontribute a sum up to but not exceeding £10 in the
¢Treni of the company being wound up.
3. Creditors: f•lllni due within one yur
202S
2024
Cr¢ditors and Accrnals
1.788
867

Anil FinAnciul SiAlemenlq
For ihc ieAr ended 30 Noi'ember 2025
T*i*iion
lThc charip. is eNcmpi from on income and gains falling wllhin section 505 of the Taxes Act 1988 as any
ci¥csv% of income oi'er expendiiure. if made. are applied to its charitoble objects.
Rosourees E%￿nded
2025
2024
Goi'ernance And $￿ppOrt eosts:
'ebsire and PR
IndeF¢ndent Examiner Fee
Jusi Gii'ino
Mark'eiin2
Miscellaneous Athninistration
1,849
921
198
29,852
83
2.920
918
52?
19.556
2,065
32.903
25.981